Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Early Phase 1
1(25.0%)
Phase 2
1(25.0%)
N/A
1(25.0%)
Phase 1
1(25.0%)
4Total
Early Phase 1(1)
Phase 2(1)
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05754073Phase 2Recruiting

Oxytocin Effects on Bone in Children With Autism Spectrum Disorder

Role: lead

NCT04789148Phase 1Recruiting

Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency

Role: lead

NCT06460948Early Phase 1Recruiting

Identifying Oxytocin Deficiency in Adults With Pituitary Disease

Role: lead

NCT04472065Not ApplicableCompleted

Study of Probiotic Use After Childbirth in Relation to Emotional Well-Being

Role: lead

All 4 trials loaded